Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.

Journal: JAMA ophthalmology
Published Date: Oct 1, 2020

Abstract

IMPORTANCE: Screening for diabetic retinopathy is recommended for children with type 1 diabetes (T1D) and type 2 diabetes (T2D), yet screening rates remain low. Point-of-care diabetic retinopathy screening using autonomous artificial intelligence (AI) has become available, providing immediate results in the clinic setting, but the cost-effectiveness of this strategy compared with standard examination is unknown.

Authors

  • Risa M Wolf
    Department of Pediatric Endocrinology and Diabetes, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Roomasa Channa
    Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI.
  • Michael D Abramoff
    Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA.
  • Harold P Lehmann
    Section on Biomedical Informatics and Data Science, Johns Hopkins University, Baltimore, MD.

Keywords

External Resources

Popular Topics
Recent Journals